<SEC-DOCUMENT>0001213900-17-012576-index.html : 20171124
<SEC-HEADER>0001213900-17-012576.hdr.sgml : 20171124
<ACCEPTANCE-DATETIME>20171124171635
ACCESSION NUMBER:		0001213900-17-012576
CONFORMED SUBMISSION TYPE:	S-1
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20171124
DATE AS OF CHANGE:		20171124

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Akers Biosciences, Inc.
		CENTRAL INDEX KEY:			0001321834
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			NJ
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-1
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-221746
		FILM NUMBER:		171221703

	BUSINESS ADDRESS:	
		STREET 1:		201 GROVE RD
		CITY:			THOROFARE
		STATE:			NJ
		ZIP:			08086
		BUSINESS PHONE:		856-848-8698

	MAIL ADDRESS:	
		STREET 1:		201 GROVE RD
		CITY:			THOROFARE
		STATE:			NJ
		ZIP:			08086

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Akers Biosciences Inc
		DATE OF NAME CHANGE:	20050325
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1
<SEQUENCE>1
<FILENAME>fs12017_akersbiosciences.htm
<DESCRIPTION>REGISTRATION STATEMENT
<TEXT>
Document 1 - file: fs12017_akersbiosciences.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>2
<FILENAME>fs12017_ex23-1akers.htm
<DESCRIPTION>CONSENT OF MORISONCOGEN, DATED NOVEMBER 24, 2017
<TEXT>
Document 2 - file: fs12017_ex23-1akers.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 3 - file: image001.jpg

</DOCUMENT>
</SEC-DOCUMENT>